Skip to main content
Equibles

Seven Fleet Capital Management LP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 2092021 MOUNTAIN VIEW, CA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$10,244,964
+$7,448,050 QoQ
Shares Held
1,504,400
+140.4% QoQ
Ownership
0.462%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#37
of 208 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Seven Fleet Capital Management LP holds $585,168,790 across 88 Biotechnology names. TSHA ranks #11 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 1,886,236 $134,017,067
2 TNGX
Tango Therapeutics, Inc.
 3,228,144 $100,911,781
3 RVMD
Revolution Medicines, Inc.
 242,029 $45,327,190
4 PHVS
Pharvaris N.V.
 774,501 $26,782,243
5 ELVN
Enliven Therapeutics, Inc.
 365,386 $18,543,339
6 ABVX
Abivax S.A.
 111,334 $14,836,368
7 AVTX
Avalo Therapeutics, Inc.
 770,765 $14,243,736
8 MIRM
Mirum Pharmaceuticals, Inc.
 110,393 $12,923,708

All Filings in TSHA

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,244,964 1,504,400
2026-03-31 $2,796,914 625,708
2025-12-31 $919,726 167,223